Seeking Alpha

Enzo Biochem (ENZ -9.3%) takes a hit after its FQ1 misses across the board. Net losses widened...

Enzo Biochem (ENZ -9.3%) takes a hit after its FQ1 misses across the board. Net losses widened Y/Y, as royalty payments declined and operating expenses jumped 11% due to higher SG&A expenses.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)